hotspot -WSS

hotspot

author：explore 2025-08-26 10:54:39 - browse：7364

Teladoc website -- health tech coverage from STAT — Adobe

Virtual care company Teladoc has a new chief executive officer following the abrupt departure of its longtime leader in April.

Chuck Divita, who took on the role Monday, previously led the commercial markets business at GuideWell, the parent company of health plan Florida Blue. He was also previously chief financial officer at FPIC Insurance Group, a publicly traded insurance company focused on medical liability.

Board chair David Snow said in a release that Divita’s health care experience and tenure at a public company made him an attractive candidate. Divita has also joined Teladoc’s board of directors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Complete sequence of Y chromosome published for first time

focus

WSS

Psilocybin's anti

PrEP can help anyone prevent HIV. Why do so few people take it?

How to make Best Hospitals ratings actually useful for patients

How a key Senate committee is planning to regulate PBMs

The response to Covid

Inside the culture of fear in the White House science office of Eric Lander

hotspot

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA panel gives mixed vote on blood pressure devices

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare explains how it will choose drugs for negotiation

Moonlake's readout produced a cash windfall. Risks remain

Mike Pence ‘not interested in trading insults’ with Trump as he tries to win New Hampshire

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare explains how it will choose drugs for negotiation

entertainment

How a key Senate committee is planning to regulate PBMs

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

My chronic pain journey would have been easier knowing 5 things % STAT

How to make AI work for medicine

Burning questions about Delta and the next phase of the Covid pandemic

knowledge

entertainment

focus

focus